Skip to main content
Premium Trial:

Request an Annual Quote

China s Shanghai Genomics Merges with Japan s GNI; Combined Firm Raises $13M

NEW YORK, June 20 (GenomeWeb News) - Japan's Gene Networks International (GNI) said today that it has merged with China's Shanghai Genomics.


GNI said that it concurrently raised a private equity round of financing of more than $13M led by Nomura, Healthcare Partners, and several other US and Japanese private equity firms.


GNI uses gene regulatory network maps and systems pharmacology techniques to develop therapeutic pharmaceutical products internally and in partnerships with other pharmaceutical firms. The company, which has offices in Japan, the UK, and the US, said that it will benefit from Shanghai Genomics' "Western-quality discovery research, preclinical development, and contract research services to facilitate cost-efficient drug development, faster revenue generation and, ultimately, profitability for the united company."


The combined company will have a research staff of more than 80 employees in Japan, China, and the UK, and several drug candidates in clinical and pre-clinical development, GNI said.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.